4/A
Changes in Ownership
Starling Oncology, Inc. Filed Acc 0001799191-22-000051
Chief Operating Officer sold 577 shares at $2.03 ($1,170)
From the SEC's structured data for this filing
Trades in this filing
Miller Matthew P · Chief Operating Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-11-15 | Sale : show line 1 in the form | −577 | $2.03 | $1,170 | 78,034 | D |
| Open-market sales · 577 sh · avg $2.03 · $1,170 | ||||||
Loading xslF345X03/edgardoc.xml…